Immune suppressive effects of increased CCL3 have been observed in melanoma and higher levels of CCR5 ligands, CCL3, CCL4 and CCL5, correlated with accumulation of CCR5 + MDSCs in melanoma lesions and tumor progression. This evidence concerns the gene CCL5 and melanoma.